Israel - Inggeris - Ministry of Health

novo nordisk ltd, israel - turoctocog alfa - powder and solvent for solution for injection - turoctocog alfa 1500 iu / 4 ml - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency).novoeight can be used for all age groups.

Israel - Inggeris - Ministry of Health

novo nordisk ltd, israel - turoctocog alfa - powder and solvent for solution for injection - turoctocog alfa 250 iu / 4 ml - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency).novoeight can be used for all age groups.

Israel - Inggeris - Ministry of Health

novo nordisk ltd, israel - turoctocog alfa - powder and solvent for solution for injection - turoctocog alfa 3000 iu / 4 ml - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency).novoeight can be used for all age groups.

Singapura - Inggeris - HSA (Health Sciences Authority)

novo nordisk pharma (singapore) pte ltd - insulin aspart (600nmol)(approx. 3.5mg) - injection, suspension - insulin aspart (600nmol)(approx. 3.5mg) 100 u/ ml

Singapura - Inggeris - HSA (Health Sciences Authority)

novo nordisk pharma (singapore) pte ltd - turoctocog alfa - injection, powder, for solution - turoctocog alfa 1000 iu/vial

Singapura - Inggeris - HSA (Health Sciences Authority)

novo nordisk pharma (singapore) pte ltd - turoctocog alfa - injection, powder, for solution - turoctocog alfa 250iu/vial

Singapura - Inggeris - HSA (Health Sciences Authority)

novo nordisk pharma (singapore) pte ltd - turoctocog alfa - injection, powder, for solution - turoctocog alfa 500iu/vial

Singapura - Inggeris - HSA (Health Sciences Authority)

novo nordisk pharma (singapore) pte ltd - turoctocog alfa - injection, powder, for solution - turoctocog alfa 2000iu/vial

Kesatuan Eropah - Inggeris - EMA (European Medicines Agency)

novo nordisk a/s - catridecacog - blood coagulation disorders, inherited - antihemorrhagics - long-term prophylactic treatment of bleeding in adult and paediatric patients 6 years and above with congenital factor-xiii-a-subunit deficiency.

New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

novo nordisk pharmaceuticals ltd - neutral insulin, human, pyr 100 iu/ml;   - solution for injection - 100 iu/ml - active: neutral insulin, human, pyr 100 iu/ml   excipient: glycerol hydrochloric acid metacresol sodium hydroxide water for injection zinc - treatment of diabetes mellitus. furthermore indicated for the initial stabilisation of diabetes, during treatment of diabetic ketoacidosis and the hyperosmolar non ketotic syndrome, and during stress situations such as severe infections and major surgery in diabetic patients.